ArticleJournal of healthcare engineering2022
Optimal Deep Learning Enabled Prostate Cancer Detection Using Microarray Gene Expression.
Article in Journal of healthcare engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Prostate cancer detection using modified transformer with optimal feature selection from MRI images.Scientific reports · 2026Article
- Framework for Race-Specific Prostate Cancer Detection Using Machine Learning Through Gene Expression Data: Feature Selection Optimization Approach.JMIR bioinformatics and biotechnology · 2025Article
- Integrative analysis of RNA expression data unveils distinct cancer types through machine learning techniques.Saudi journal of biological sciences · 2024Article
- Cancer genetics and deep learning applications for diagnosis, prognosis, and categorization.Journal of biological methods · 2024Review
- Multi-omics based artificial intelligence for cancer research.Advances in cancer research · 2024Review
- Advancing prostate cancer detection: a comparative analysis of PCLDA-SVM and PCLDA-KNN classifiers for enhanced diagnostic accuracy.Scientific reports · 2023Article
- Machine Learning Methods for Cancer Classification Using Gene Expression Data: A Review.Bioengineering (Basel, Switzerland) · 2023Review
- OEDL: an optimized ensemble deep learning method for the prediction of acute ischemic stroke prognoses using union features.Frontiers in neurology · 2023Article
- Advances and development of prostate cancer, treatment, and strategies: A systemic review.Frontiers in cell and developmental biology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate cancer is the main cause of death over the globe. Earlier detection and classification of cancer is highly important to improve patient health. Previous studies utilized statistical and machine learning (ML) techniques for prostate cancer detection. However, several challenges that exist in the investigation process are the existence of high dimensionality data and less number of training samples. Metaheuristic algorithms can be used to resolve the curse of dimensionality and improve the detection rate of artificial intelligence (AI) techniques. With this motivation, this article develops an artificial intelligence based feature selection with deep learning model for prostate cancer detection (AIFSDL-PCD) using microarray gene expression data. The AIFSDL-PCD technique involves preprocessing to enhance the input data quality. In addition, a chaotic invasive weed optimization (CIWO) based feature selection (FS) technique for choosing an optimal subset of features shows the novelty of the work. Moreover, the deep neural network (DNN) model can be applied as a classification model to detect the existence of prostate cancer in the microarray gene expression data. Furthermore, the hyperparameters of the DNN model can be effectively adjusted by the use of RMSprop optimizer. The design of CIWO based FS technique helps for reducing the computational complexity and improve the classification accuracy. The experimental results highlighted the betterment of the AIFSDL-PCD approach on the other techniques with respect to distinct measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.